Status:
COMPLETED
Comparison of Central Venous Catheters With Silver Nanoparticles Versus Conventional Catheters
Lead Sponsor:
Catholic University of the Sacred Heart
Collaborating Sponsors:
ISS, Dip.Tecnologie e Salute, Prof. Gianfranco Donelli
Conditions:
Central Venous Catheter Related Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Bloodstream infections are common in Intensive Care Units (ICUs). The need of a central venous line increases the risk of bacteremia and central venous catheter (CVC) related infections. The use of ca...
Detailed Description
RATIONALE Central venous catheter (CVC) infections are one of the major causes of infections acquired in intensive care unit (ICU) patients. About 25% of bloodstream infections recorded in ICUs are s...
Eligibility Criteria
Inclusion
- Patients will be eligible when insertion of a central venous catheter (CVC) at a new site (subclavian or internal jugular) has to be planned for therapy or monitoring of at least 3-day duration.
Exclusion
- Age below 18 years and all patients with a history of failed catheterization attempts or the need for catheterization at a site of previous surgery, skeletal deformity, or scarring.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
472 Patients enrolled
Trial Details
Trial ID
NCT00337714
Start Date
July 1 2006
End Date
September 1 2008
Last Update
May 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSC, Policlinico Universitario A. Gemelli, ICU
Rome, Rome, Italy, 00168